Amniotic Fluid Embolism (AFE) Foundation

Amniotic Fluid Embolism (AFE) Foundation is a non-profit organization founded in 2008 with a mission to reduce maternal and infant mortality attributed to amniotic fluid embolism. The foundation has made significant strides in bringing together families, survivors, medical professionals, and researchers to advocate for greater awareness and resources to combat AFE. This collective effort has resulted in the establishment of an internationally recognized research program, sought-after educational programming for healthcare providers, and a global network of support groups and resources for those affected by AFE. The AFE Foundation is dedicated to identifying the cause, diagnosis, prevention, and treatment of amniotic fluid embolism. Through educational and support programs, they aim to provide information and resources to healthcare providers and affected families. By shedding light on this rare condition, the foundation has played a crucial role in helping tens of thousands of people gain knowledge, understanding, and support during challenging times. In a field where information and support were previously scarce, The AFE Foundation has emerged as a guiding light for those impacted by AFE, offering assurance and assistance as they navigate their way forward. This initiative holds promising potential within the Health Care industry and signifies a crucial step towards addressing a previously overlooked area of healthcare. While the specific investment details and current investors are not available, the impactful work undertaken by The AFE Foundation makes it a compelling prospect for potential venture capital interest, as its societal and potential financial impact is substantial.